May 17, 2008
Reject a Melnyk slate, Biovail shareholders urged
Troubled drug maker Biovail Corp. is urging shareholders to reject any slate of dissident directors that its controversial estranged founder Eugene Melnyk may propose, saying the company's future is on the ...
Read full story from The Globe and Mail
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Claims administrator: Interim payments in $4.85... | 2 hr | Jerimiah | 1048 |
| Vioxx claimants rush to join $4.85B settlement ... (from Jan '08) | 3 hr | Jerimiah | 684 |
| MPI Research cutting jobs in Mattawan | 4 hr | Former MPI E... | 18 |
| Cymbalta leads the way for Lilly (from Feb '07) | 5 hr | Stranger In ... | 234 |
| Merck to fund Vioxx settlement in August | 7 hr | Peggy | 1375 |
| Northwestern Memorial Hospital patient's compla... | 8 hr | Old RN | 2 |
| Johnson & Johnson buying Mentor for $1.07B | 9 hr | Anon Amous | 3 |
Libra
Most Popular